Abanid, Viola B.

HRN: 01-45-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2025
CEFUROXIME 750MG (VIAL)
04/14/2025
04/21/2025
IV
1.5g As LD Then 750mg
Q8
Mouth Sores
Rejected 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines